BioSpace News Archive

Policy

ERS Genomics and Lonza Enter Into CRISPR/Cas9 Technology Licensing Deal

ERS Genomics Limited and Lonza Pharma & Biotech announced today a license agreement to provide Lonza with access to ERS Genomics’ CRISPR/Cas9 genome editing technology patents.

December 13, 2018
·
1 min read
Business

Boehringer Ingelheim and Lilly Partner with Duke Clinical Research Institute to Advance Multidisciplinary Care for People with Type 2 Diabetes and Cardiovascular Disease

The Duke Clinical Research Institute (DCRI) is leading a new clinical study to optimize care for people with type 2 diabetes and cardiovascular disease through evaluation of a multidisciplinary approach at cardiology clinics across the U.S.

December 13, 2018
·
7 min read
FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE)

Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to baricitinib,

December 13, 2018
·
12 min read
Aurora Cannabis Expands Retail Exposure Through Strategic Investment in High Tide

Participating in a Rapidly Growing Cannabis and Lifestyle Accessories Retailer

December 13, 2018
·
9 min read
Policy

Check-Cap Announces FDA Conditional Approval of IDE to Initiate U.S. Pilot Study of C-Scan®

Study to begin upon review and approval of Institutional Review Board (IRB)

December 13, 2018
·
4 min read
Drug Development

Protagonist Therapeutics Initiates Phase 1 Trial of Oral, Gut-Restricted, Alpha-4-Beta-7 Integrin Antagonist PN-10943

PN-10943 begins clinical development as a potential novel oral therapy for patients with inflammatory bowel disease

December 13, 2018
·
4 min read
Biotech Bay

Zymergen Announces $400 Million in Series C Funding led by the SoftBank Vision Fund

Zymergen, the world’s first molecular manufacturing technology company, announced today it has raised over $400 million in Series C funding led by returning investor SoftBank Vision Fund.

December 13, 2018
·
5 min read
Business

When Your Holiday Guest Is An Addict

It’s every holiday host’s worse nightmare: a guest who is an alcoholic or a drug addict. When not inviting the guest — a loved one, a professional partner or associate — is not an option, how do you prepare for the worst-case scenario?

December 13, 2018
·
2 min read
Policy

Kali-Extracts Anticipates Explosive Growth in $22 Billion CBD Market Expected to Result From Hemp Farming Legalization Included in $867 Billion Farm Bill

Congress passed the $867 billion farm bill that includes the legalization of hemp farming and President Trump is expected to soon sign the bill into law.

December 13, 2018
·
2 min read
Business

ForeverGreen Achieves Major Financial Milestones

Operational Profitability and Improved Net Margins Remain Top Priorities

December 13, 2018
·
2 min read